Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for erectile dysfunction.

Muammer Kendirci1, Serap Gur, Suresh C Sikka

  • 1Department of Urology, Tulane University Health Sciences Center, New Orleans, LA 70112-2699, USA.

Frontiers in Bioscience : a Journal and Virtual Library
|June 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spermatozoa Proteins Involved in ROS Generation and Antioxidant Defense Are Differentially Acetylated in Idiopathic Infertility.

Antioxidants (Basel, Switzerland)·2025
Same author

Nanoantioxidants and Their Potential Use in the Management of Oxidative Stress-Associated Male Infertility.

Frontiers in bioscience (Landmark edition)·2025
Same author

Comparative Proteomics of Seminal Exosomes Reveals Size-Exclusion Chromatography Outperforms Ultracentrifugation.

Biomedicines·2025
Same author

Plasma circulating extracellular vesicles reveal dysregulation of synaptic signaling in SHIV-infected rhesus macaque.

Cell communication and signaling : CCS·2025
Same author

An updated narrative review on revolutionizing erectile dysfunction treatment: the crucial role of trophic factors in Adipose-Derived stem cell therapy.

BMC urology·2025
Same author

Role of Metabolic Syndrome in Male Fertility: Is It a Risk Factor?

Archivos espanoles de urologia·2025

Gene therapy offers a promising new avenue for treating erectile dysfunction (ED) when oral medications like PDE5 inhibitors fail. Research focuses on the nitric oxide pathway for effective ED gene therapy strategies.

Area of Science:

  • Urology
  • Molecular Biology
  • Pharmacology

Background:

  • Erectile dysfunction (ED) affects a significant portion of the male population.
  • Current treatments, including phosphodiesterase type 5 (PDE5) inhibitors, are effective for many but fail in specific conditions like diabetic or postprostatectomy ED.
  • Limited success rates (50-60%) with PDE5 inhibitors necessitate novel therapeutic approaches.

Purpose of the Study:

  • To review the advancements and potential of gene therapy as a treatment for erectile dysfunction.
  • To explore the physiological basis and gene therapy strategies targeting the nitric oxide signaling pathway in erectile function.
  • To discuss the various vector systems employed in ED gene therapy research.

Main Methods:

  • Review of existing literature on gene therapy for ED.

Related Experiment Videos

  • Analysis of the role of the nitric oxide (NO)/guanylate cyclase (GC)/cyclic guanosine monophosphate (cGMP) pathway in erectile physiology.
  • Examination of different viral and nonviral vectors, including advanced adenovirus vectors, for gene delivery.

    • Main Results:

    • Gene therapy presents a viable therapeutic option for ED, particularly for cases refractory to PDE5 inhibitors.
    • The NO/cGMP pathway is a key target for gene therapy interventions aimed at restoring erectile function.
    • Various gene delivery vectors have been utilized, with newer generations showing reduced toxicity and improved efficiency.

    Conclusions:

    • Gene therapy holds significant promise for treating complex cases of erectile dysfunction.
    • Targeting the NO/cGMP pathway through gene therapy offers a rational approach to restoring erectile function.
    • Ongoing research and development of efficient and safe gene delivery vectors are crucial for clinical translation.